Results 91 to 100 of about 2,347,326 (232)

Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network [PDF]

, 2011
Clinically and biologically, nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has much more in common with germinal-center derived B-cell non-Hodgkin lymphoma (NHL) than with classical Hodgkin lymphoma (cHL).
Diehl V, Fanale MA, Hasenclever D, Katrina Farrell, Mike Leach, Orlandi E, Pamela Mckay, Savage KJ, Stein H   +8 more
core   +1 more source

Classical Hodgkin’s lymphoma shows epigenetic features of abortive plasma cell differentiation

Haematologica, 2011
Background Epigenetic changes are involved in the extinction of the B-cell gene expression program of classical Hodgkin’s lymphoma. However, little is known regarding epigenetic similarities between cells of classical Hodgkin’s lymphoma and plasma cell ...
Volkhard Seitz, Philippe E. Thomas, Karin Zimmermann, Ulrike Paul, Anke Ehlers, Maria Joosten, Lora Dimitrova, Dido Lenze, Anke Sommerfeld, Elisabeth Oker, Ulf Leser, Harald Stein, Michael Hummel   +12 more
doaj   +1 more source

Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL). [PDF]

, 2019
Angioimmunoblastic T-cell lymphoma (AITL) is one of four major subtypes of nodal peripheral T cell lymphoma, characterized by its cell of origin, the follicular helper T-cell (TFH).
Alpdogan, Onder, Gong, Jerald Z., Haverkos, Bradley M., Johnson, William T., Kartan, Saritha, Nikbakht, Neda, Porcu, Pierluigi, Sokol, Kelsey   +7 more
core   +1 more source

The frequency of occurrence and nature of recombinant feline leukemia viruses in the induction of multicentric lymphoma by infection of the domestic cat with FeLV-945 [PDF]

, 1970
During feline leukemia virus (FeLV) infection in the domestic cat, viruses with a novel envelope gene arise by recombination between endogenous FeLV-related elements and the exogenous infecting species. These recombinant viruses (FeLV-B) are of uncertain
Ahmad, Shamim, Levy, Laura S.
core   +1 more source

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

bioRxiv, 2019
B-cell non-Hodgkin’s lymphoma (B-NHL) encompasses multiple clinically and phenotypically distinct subtypes of malignancy with unique molecular etiologies.
Michael R. Green, Non-Hodgkin Lymphoma, M. Chun, John Man-shun Ma, Saber Tadros, Alyssa Bouska, Tayla B. Heavican, Haopeng Yang, Q. Deng, D. Moore, A. Akhter, K. Hartert, N. Jain, Jordan Showell, Sreejoyee Ghosh, L. Street, M. Davidson, Christopher D. Carey, J. Tobin, Deepak Perumal, J. Vose, M. Lunning, A. Sohani, Benjamin J Chen, S. Buckley, L. Nastoupil, R. Davis, J. Westin, N. Fowler, S. Parekh, M. Gandhi, S. Neelapu, D. Stewart, K. Bhalla, J. Iqbal, T. Greiner, S. Rodig, A. Mansoor   +37 more
semanticscholar   +1 more source

Intravascular large B-cell lymphoma

Przegląd Dermatologiczny, 2021
Agnieszka Odziomek, Piotr Jarliński, Ewelina Rebizak, Jolanta Węgłowska   +3 more
doaj   +1 more source

T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response

Haematologica, 2010
Background Gene expression profiling has successfully identified the prognostic significance of the host response in lymphomas. The aggressive T-cell/histiocyte-rich large B-cell lymphoma and the indolent nodular lymphocyte-predominant Hodgkin’s lymphoma
Peter Van Loo, Thomas Tousseyn, Vera Vanhentenrijk, Daan Dierickx, Agnieszka Malecka, Isabelle Vanden Bempt, Gregor Verhoef, Jan Delabie, Peter Marynen, Patrick Matthys, Chris De Wolf-Peeters   +10 more
doaj   +1 more source

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Journal of Clinical Oncology, 2019
PURPOSE High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (HGBL-DH/TH) has a poor outcome after standard chemoimmunotherapy. We sought to understand the biologic underpinnings of HGBL-DH/TH with BCL2 rearrangements (HGBL-DH/TH- BCL2)
Daisuke Ennishi, A. Jiang, M. Boyle, B. Collinge, B. Grande, S. Ben-Neriah, C. Rushton, Jeffrey Tang, N. Thomas, G. Slack, P. Farinha, K. Takata, T. Miyata-Takata, J. Craig, A. Mottok, B. Meissner, Saeed Saberi, Ali Bashashati, D. Villa, K. Savage, L. Sehn, R. Kridel, A. Mungall, M. Marra, Sohrab P. Shah, C. Steidl, J. Connors, R. Gascoyne, Ryan D. Morin, D. Scott   +29 more
semanticscholar   +1 more source

Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma

Hematology Reports, 2011
The determination of prognosis for B-Non- Hodgkin’s lymphoma (NHL) is known to be related to the multiple differences in tumor cell biology. Bcl-2 and Bcl-6 are two markers linked to germinal center B cells.
Hanan Mohamed Mahmoud, Yasmin Nabil Elsakhawy   +1 more
doaj   +1 more source

Safety and feasibility of anti-CD19 CAR T cells with fully-human binding domains in patients with B-cell lymphoma

Nature Medicine, 2019
Anti-CD19 chimeric antigen receptor (CAR)-expressing T cells are an effective treatment for B-cell lymphoma, but often cause neurologic toxicity.
Jennifer N. Brudno, Norris Lam, Danielle Vanasse, Yueh-wei Shen, J. Rose, J. Rossi, A. Xue, A. Bot, N. Scholler, Lekha Mikkilineni, M. Roschewski, R. Dean, R. Cachau, Philippe Youkharibache, Rashmika Patel, B. Hansen, D. Stroncek, S. Rosenberg, R. Gress, J. Kochenderfer   +19 more
semanticscholar   +1 more source